老年退行性二尖瓣反流行二尖瓣修复术的临床结局
该回顾性研究分析了1998年1月至2017年6月共343例年龄≥75岁因退行性二尖瓣反流行二尖瓣修复术患者的临床结果,中位随访7.4年。手术死亡率为1.2%,1、5、10年累积二尖瓣再手术率分别为2.2%、3.2%、3.2%,总体生存率分别为95%、83%、51%。作者认为老年患者行二尖瓣修复术手术死亡率低,仍是退行性二尖瓣反流的首选治疗。
要点
- 年龄≥75岁患者行二尖瓣修复术手术死亡率为1.2%。
- 中位随访7.4年,10年累积二尖瓣再手术率为3.2%。
- 1、5、10年总体生存率分别为95%、83%、51%。
核心结论
- 老年患者行二尖瓣修复术可实现低手术死亡率和低并发症。
- 老年退行性二尖瓣反流患者行二尖瓣修复术仍是首选治疗。
研究设计与样本
- 回顾性分析1998年1月至2017年6月共343例年龄≥75岁、以退行性二尖瓣反流为主要指征行二尖瓣修复术患者的临床结果。
主要发现
- 患者中位年龄(四分位距)为79.4(76.9,82.9)岁,女性132例(38.5%)。
- 123例患者行同期手术:三尖瓣手术68例(19.8%),迷宫手术或肺静脉隔离55例(16.0%)。
- 手术死亡率为1.2%;手术并发症包括心房颤动37.9%、延长机械通气7.0%、起搏器植入3.8%、需透析的肾功能衰竭1.5%、卒中3例(0.9%)。
- 中位随访7.4年(四分位距3.5-14.1年);1、5、10年累积二尖瓣再手术率分别为2.2%、3.2%、3.2%;1、5、10年总体生存率分别为95%、83%、51%。
- 高龄、吸烟、超重和体重不足与死亡风险增加相关,较高的左心室射血分数和高血压与死亡风险降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study analyzes the safety and outcomes of mitral valve repair for degenerative mitral valve regurgitation in patients 75 years of age or older. METHODS: We retrospectively reviewed the clinical results of 343 patients aged ≥75 years who underwent mitral valve repair for degenerative mitral valve regurgitation as a primary indication between January 1998 and June 2017. RESULTS: The median (interquartile range) age of the patients was 79.4 (76.9, 82.9) years, and 132 (38.5%) patients were women. Concomitant procedures were performed in 123 patients: tricuspid surgery in 68 (19.8%) and a maze procedure or pulmonary vein isolation in 55 (16.0%). Operative mortality was 1.2%. Operative complications included atrial fibrillation in 37.9%, prolonged ventilation in 7.0%, pacemaker implantation in 3.8, renal failure requiring dialysis in 1.5 and stroke in 3 (0.9%). The median follow-up was 7.4 years (interquartile range, 3.5-14.1 years). The cumulative incidence rates of mitral valve reoperation were 2.2%, 3.2% and 3.2% at 1, 5 and 10 years, respectively. Overall survival at 1, 5 and 10 years were 95%, 83% and 51%, respectively. Older age, smoking and over and underweight were associated with increased risk of mortality, while higher left ventricular ejection fraction and hypertension were associated with reduced risk. CONCLUSIONS: Mitral valve repair in elderly patients can be accomplished with low operative mortality and complications. Mitral valve repair in the elderly remains the preferred treatment for degenerative mitral regurgitation.
引用
- Kawajiri H, Schaff HV, Dearani JA, et al. Clinical outcomes of mitral valve repair for degenerative mitral regurgitation in elderly patients. Eur J Cardiothorac Surg. 2022. PMID: 35532171. doi:10.1093/ejcts/ezac299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。